ARTICLE | Company News
Genelabs, GlaxoSmithKline deal
January 12, 2009 8:00 AM UTC
GlaxoSmithKline completed its previously announced tender offer for Genelabs, acquiring about 39.3 million shares (89%) at $1.30. GlaxoSmithKline plans to acquire the remaining shares at the same pric...